“The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE: PolaRCHP vs. RCHOP for older patients” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025070. doi:10.4084/MJHID.2025.070.